about
Genetic, hormonal and metabolic aspects of PCOS: an updateHormonal contraceptives: pharmacology tailored to women's healthRandomized control study of the effects of raloxifene on serum lipids and homocysteine in older women.Menopause, the cardiovascular risk factor homocysteine, and the effects of treatment.The safety of veralipride.Antioxidants reduce oxidative stress in follicular fluid of aged women undergoing IVF.Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.Present and future of recombinant gonadotropins in reproductive medicine.Hormonal therapy for endometriosis: from molecular research to bedside.[Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina® and D-mannose in recurrent urinary infections in perimenopausal women].Short-term treatment of uterine fibromyomas with danazol.Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).Effects of dexamethasone and dexamethasone plus naltrexone on pituitary response to GnRH and TRH in normal women.Sperm quality and pregnancy rate after COX-2 inhibitor therapy of infertile males with abacterial leukocytospermia.Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome.New protocol of clomiphene citrate treatment in women with hypothalamic amenorrhea.Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata.Infertility and psychiatric morbidity.Effects of the selective estrogen receptor modulator, raloxifene, on carotid artery pulsatility index in postmenopausal women.The cardiovascular risk factor homocysteine is not elevated in young women with hyperandrogenism or hypoestrogenism.Hemodynamic effect of danazol therapy in women with uterine leiomyomata.Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women.Sperm quality improvement after natural anti-oxidant treatment of asthenoteratospermic men with leukocytospermia.Mental health, pain symptoms and systemic comorbidities in women with endometriosis: a cross-sectional study.Human chorionic gonadotropin, thyroid function, and immunological indices in threatened abortion.Hypothalamo-pituitary-adrenal axis and adrenal function before and after ovariectomy in premenopausal women.A prospective, randomised, investigator-blind, controlled, clinical study on the clinical efficacy and tolerability of two highly purified hMG preparations administered subcutaneously in women undergoing IVF.[Role of vitamin D in female reproduction].Therapeutic approach for metabolic disorders and infertility in women with PCOS.Combined oral contraceptives in women with menstrual migraine without aura.Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety.Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.Successful multiple pregnancy achieved after transfer of frozen embryos obtained via intracytoplasmic sperm injection with testicular sperm from an AZFc-deleted man.Human sperm aneuploidy: FISH analysis in fertile and infertile menEffects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal womenMetformin treatment is effective in obese teenage girls with PCOSMatrix metalloproteinases and their inhibitors in human cumulus and granulosa cells as biomarkers for oocyte quality estimation.
P50
Q26740034-36461EF0-AFAF-42E2-AC12-4CD0BAFA26C6Q26745814-06E3C906-D50F-4579-AADA-D1D3555E15B1Q32067330-4D79B4D6-8588-4E57-A383-9E630D6F583CQ35931226-B0928785-F004-47B3-BC34-0C79EE996E73Q36565056-F97AFCF0-515C-4D7C-AD14-A10BB7C513C6Q37240174-78348BE1-031D-415B-9FBB-9B155FDAB2E4Q37672998-973E4B83-54DB-4F10-A2F4-3B1EEE6DCB82Q37887024-9D0ECCAE-B6D8-47E1-B9EB-BBA0F7872D0BQ38833136-E62CCB2C-8956-4721-B5F0-465BEB1BC798Q39154345-A82E1D9F-23D3-4FDC-AEDB-97A0F64BBD7DQ39438659-D08DE176-B478-48E1-B271-133B7614488EQ42463314-D1457D98-155F-41FA-9E88-B058DA02B2C6Q42472813-CA19F160-541E-4750-A162-013C64F6408DQ42506470-3A5EA7E2-D892-488B-8893-EC54E080BE7FQ42510818-8D498197-B59D-43B3-8B0D-EE03069D6013Q42528609-1F78942F-2B47-45FB-9059-7BC93E7C7D80Q42625627-C138CF51-49B7-42BF-A022-0BFC2927904AQ42939339-C6A0588F-443C-4A44-84A7-BFE35129F95DQ43441552-480F1C91-A090-45DC-9BAF-3571374DE35EQ43538175-CC7F5A1D-39B0-4D11-ADD2-780C5CE275B4Q43782548-659EDD7B-4EE0-44F8-9C1B-0EAF87D23730Q43967833-99CBDD8F-C8E8-49C8-9B4C-F74AF9AB1F8AQ44108526-D0AB40FC-B014-4F64-96A3-321350D8B292Q44435043-4B5DE1AF-A72E-4FC2-B955-AC5F55657881Q45006995-62B04118-73BA-481F-A5DA-E6D89207D984Q46837949-5ED8F681-E6ED-49CB-BE8A-9AAB1F0A0005Q47598319-2FF8A82B-F27A-417A-8509-D659E78382E8Q47703745-71FD49C6-984D-4313-AE29-53D5D1E4FDB0Q48474791-D8B41E86-AE7F-4E24-A1F3-C7381AB8E564Q48625505-B6383FC5-AFBB-4DD8-83AB-B251095E5993Q50052871-150CCF04-6916-47D9-8172-BF55C325F785Q50428675-3A3AD512-3130-4940-9E77-DD35D44F3FBAQ51015226-A308E2EC-BC8E-411E-9EC9-BF14834F2C79Q51063576-0DA09825-33B3-4CA1-B5CA-8EAA33A9241BQ51339024-0B600983-4438-49F1-83CD-47394452664EQ51567237-4AE89BB9-DDDD-4FC8-9274-8AACF5968B9CQ61854982-92BBFAD4-DBC1-499D-9452-7A606A83634BQ61855030-15D93378-3513-45E6-B9EE-6946FA5D9E43Q61855036-5FE65220-AC3D-4134-89E0-E77A528769AFQ64943947-CE6C5F70-09C1-41CD-A3A7-AD9378BB8CB5
P50
description
researcher ORCID ID = 0000-0001-5024-2321
@en
name
Giuseppe Morgante
@ast
Giuseppe Morgante
@en
Giuseppe Morgante
@es
Giuseppe Morgante
@nl
type
label
Giuseppe Morgante
@ast
Giuseppe Morgante
@en
Giuseppe Morgante
@es
Giuseppe Morgante
@nl
prefLabel
Giuseppe Morgante
@ast
Giuseppe Morgante
@en
Giuseppe Morgante
@es
Giuseppe Morgante
@nl
P1153
7003601376
P21
P31
P496
0000-0001-5024-2321